New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
The Oncology Institute, Inc.
TOI
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

25M

Medical - Care Facilities

Next Earning date - 13 Nov 2024

25M

Medical - Care Facilities

Next Earning date - 13 Nov 2024

0.33USD
0.00 ( 0.00%)
favorite-chart

Relative Strenght

92
favorite-chart

Volume Buzz

-57%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

88%

Quote Panel

Shape
Updated October 17, 2024
1W 4.15 % 1M 9.67 % 3M -36.73 % 1Y -79.69 %

Key Metrics

Shape
  • Market Cap

    24.84M


  • Shares Outstanding

    75.49M


  • Share in Float

    33.20M


  • Dividende

    0


  • Earning Date

    13 Nov 2024


  • Price Target

    0.329


  • Average Volume

    127465


  • Beta

    0.614


  • Range

    0.273-2.655


  • Industry

    Medical - Care Facilities


  • Website

    https://theoncologyinstitute.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.07x

P/S Ratio

0.82x

P/B Ratio

3.3

Debt/Equity

-17.1%

Net Margin

$-0.8

EPS

How TOI compares to sector?

P/E Ratio

Relative Strength

Shape

TOI

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$483M

Shape390%

2025-Revenue

$0.17

Shape0%

2025-EPS

$67M

Shape-352%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Jefferies

initialise

Previous: Not converted

2022-08-15

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.17
vs -0.04

Q4.22

arrow
arrow

N/A

-0.16
vs -0.15

Q1.23

arrow
arrow

N/A

-0.10
vs -0.29

Q2.23

arrow
arrow

N/A

-0.19
vs -0.06

Q3.23

arrow
arrow

N/A

-0.19
vs -0.17

Q4.23

arrow
arrow

N/A

-0.21
vs -0.16

Q1.24

arrow
arrow

N/A

-0.22
vs -0.10

Q2.24

arrow
arrow

N/A

-0.17
vs -0.19

Q3.24

arrow
arrow

N/A

-0.07
vs -0.19

Q4.24

arrow
arrow

N/A

-0.08
vs -0.21

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+24%

65M  vs 52.3M

Q4.22

arrow
arrow

+37%

71.4M  vs 52.3M

Q1.23

arrow
arrow

+38%

76.2M  vs 55.2M

Q2.23

arrow
arrow

+32%

80.2M  vs 60.9M

Q3.23

arrow
arrow

+26%

82M  vs 65M

Q4.23

arrow
arrow

+20%

85.8M  vs 71.4M

Q1.24

arrow
arrow

+24%

94.7M  vs 76.2M

Q2.24

arrow
arrow

+23%

98.6M  vs 80.2M

Q3.24

arrow
arrow

+31%

107.5M  vs 82M

Q4.24

arrow
arrow

+27%

109.1M  vs 85.8M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-2%

-0.02
vs -0.04

Q4.22

arrow
arrow

-8%

-0.08
vs -0.02

Q1.23

arrow
arrow

-30%

-0.30
vs -0.08

Q2.23

arrow
arrow

-20%

-0.20
vs -0.30

Q3.23

arrow
arrow

-24%

-0.24
vs -0.20

Q4.23

arrow
arrow

-27%

-0.27
vs -0.24

Q1.24

arrow
arrow

-39%

-0.39
vs -0.27

Q2.24

arrow
arrow

-43%

-0.43
vs -0.39

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

39

39
vs 36

8%

Q4.22

arrow
arrow

39

39
vs 39

NA

Q1.23

arrow
arrow

39

39
vs 39

NA

Q2.23

arrow
arrow

36

36
vs 39

-8%

Q3.23

arrow
arrow

36

36
vs 36

NA

Q4.23

arrow
arrow

46

46
vs 36

28%

Q1.24

arrow
arrow

46

46
vs 46

NA

Q2.24

arrow
arrow

39

39
vs 46

-15%

Earnings Growth

Latest News